Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Recruiting now · Phase 1
Conditions studied: Non-small Cell Lung Cancer, Colorectal Carcinoma, Pancreatic Ductal Adenocarcinoma, Endometrial Cancer, Solid Tumor, Adult, KRAS G12D
In brief
Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.
Key facts
- Study ID
- NCT06218914
- Run by
- AstraZeneca
- People needed
- 108
- Starts
- 2024-03-22
- Expected to finish
- 2043-11-18
- Last updated by the study team
- 2026-07-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Duarte, California, United States (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — Newport Beach, California, United States (enrolling)
- Research Site — Jacksonville, Florida, United States (enrolling)
- Research Site — Chicago, Illinois, United States (enrolling)
- Research Site — Westwood, Kansas, United States (enrolling)
- Research Site — Boston, Massachusetts, United States (enrolling)
- Research Site — St Louis, Missouri, United States (enrolling)
- Research Site — New York, New York, United States (enrolling)
- Research Site — New York, New York, United States (enrolling)
- Research Site — Portland, Oregon, United States (enrolling)
- Research Site — Philadelphia, Pennsylvania, United States (enrolling)
- Research Site — Pittsburgh, Pennsylvania, United States (enrolling)
- Research Site — Nashville, Tennessee, United States (enrolling)
- Research Site — Dallas, Texas, United States (enrolling)
- Research Site — Galveston, Texas, United States (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Milwaukee, Wisconsin, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.